The adaptive transition of glioblastoma stem cells and its implications on treatments
Abstract Glioblastoma is the most malignant tumor occurring in the human central nervous system with overall median survival time <14.6 months. Current treatments such as chemotherapy and radiotherapy cannot reach an optimal remission since tumor resistance to therapy remains a challenge. Gliobla...
Main Authors: | Zeyu Wang, Hao Zhang, Shengchao Xu, Zhixiong Liu, Quan Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00491-w |
Similar Items
-
Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment
by: Dongye Yi, et al.
Published: (2018-03-01) -
Glioblastoma Stem-Like Cells—Biology and Therapeutic Implications
by: John A. Boockvar, et al.
Published: (2011-06-01) -
Pentraxin 3 Promotes Glioblastoma Progression by Negative Regulating Cells Autophagy
by: Zeyu Wang, et al.
Published: (2020-08-01) -
Targeting Cancer Stem Cells for Treatment of Glioblastoma Multiforme
by: Der-Yang Cho, et al.
Published: (2013-04-01) -
Neural Stem Cells of the Subventricular Zone as the Origin of Human Glioblastoma Stem Cells. Therapeutic Implications
by: Esperanza R. Matarredona, et al.
Published: (2019-08-01)